HPLC purity 98% vs 99%: what the percentage really tells you

Purity is the first number most buyers check on a research peptide. Product pages show 98% and 99% side by side, and the gap looks small. In practice it matters for reproducibility, for how you read your results and for how much of the vial is really the compound named on the label. This guide explains what the purity figure measures, how the peak area is calculated, which impurities are typical of peptide synthesis, why TFA salt changes the picture and why HPLC should be paired with mass spectrometry.

What the HPLC purity percentage means

HPLC purity is the share of the signal that belongs to the main compound, out of all the signals on the chromatogram. The separation is usually run in reversed-phase mode with UV detection. For peptides, analysts commonly choose a wavelength around 214 to 220 nm, because peptide bonds absorb strongly in that range.

If the chromatogram shows one dominant peak whose area is 98.5% of the total, the reported purity is 98.5%. That is a relative value based on UV signal. It is not a direct measurement of mass.

The key caveat is simple. The percentage tells you what fraction of the UV signal belongs to the main component, but not what fraction of the powder is peptide. Two lots with identical HPLC purity can still differ in salt, water and residual solvent content, so read the figure alongside the other analytical data.

How the peak area is calculated

Every peak on the chromatogram has an area, which is the integrated signal over retention time. The software integrates the main peak and divides it by the sum of all peak areas. Three practical consequences follow:

• peaks below the integration threshold may not be counted,
• compounds that absorb UV strongly appear more prominently, while weak absorbers can be underestimated,
• changing the gradient, column or wavelength alters the peak profile, so results should only be compared within the same method.

None of this makes the number meaningless. It makes it a comparison tool within one validated method, not a replacement for every other measurement.

Why 98% and 99% are not the same

One percentage point sounds minor, but in impurity terms it is a doubling. At 98% purity, up to 2% of the signal belongs to other species. At 99%, the figure drops to 1%. If your study compares a biological response to a specific compound, every additional component is a variable that is hard to attribute later.

Feature	98% purity	99% purity
Signal from non-target peaks	up to 2%	up to 1%
Number of possible confounding variables	higher	lower
Typical use	preliminary method work	repeatable studies and comparisons
Impurity interpretation by MS	needs more attention	easier to interpret

Peptide impurities: deletions and truncated sequences

Solid-phase peptide synthesis builds the chain one amino acid at a time. Each coupling step has an efficiency below 100%, and each incomplete coupling leaves a trace. The most common impurities are:

• deletion sequences, where one or more residues are missing from inside the chain,
• truncated sequences, which stopped growing before the intended end of the chain.

Other by-products come from protecting groups and from modifications such as methionine oxidation or deamidation of asparagine and glutamine. Many of these carry a mass close to the target peptide, so they can elute right beside the main peak and be hard to separate.

Sequence length matters here. Tesamorelin is a longer peptide of 44 residues, which means more coupling steps where a deletion can occur. BPC-157 is shorter, with 15 residues. That simplifies the analysis, although it does not remove the need for quality control.

TFA salt and net peptide content

Many peptides are purified by reversed-phase HPLC using trifluoroacetic acid (TFA) in the mobile phase. After lyophilisation, some TFA counter-ions remain bound to the peptide’s positive charges. The result is a salt, and the salt adds mass that is not peptide.

So two separate concepts need to be kept apart:

• HPLC purity, the share of the main component in the UV signal,
• net peptide content, the percentage of the powder’s weight that is the peptide itself.

Net peptide content is often noticeably lower than HPLC purity, because salt, water and other non-peptide material count toward the weight. This is normal when the supplier states the salt form and how content was determined. When you compare reagents, look at both figures and check whether the product description explains what the vial actually contains.

Why mass spectrometry complements HPLC

HPLC tells you how much UV signal each peak carries. Mass spectrometry (MS) tells you the molecular mass behind that signal. The two methods answer different questions, which is why peptide analysis uses them together.

Combined, they provide three things:

• confirmation that the main peak has the expected molecular mass,
• detection of deletion and truncated sequences, which differ in mass from the target,
• recognition of modifications, such as oxidation, through a characteristic mass shift.

HPLC alone cannot say what the other peaks are. MS fills much of that gap by assigning a mass to each signal. This is why MOLEVIA confirms the mass of every batch by MS, and why our HPLC purity is 99% or higher.

To see how we run quality control, visit our quality page. If you prepare solutions in the lab, the concentration calculator helps with the arithmetic. The peptides discussed here are tesamorelin and BPC-157. All of our products are sold as research reagents, so please also review our Research Use Only information.

Key takeaways

• HPLC purity measures the UV signal share of the main component, not the peptide mass in the vial.
• Peak area depends on method, integration threshold and wavelength, so compare results from the same analysis.
• Some by-products and modifications have masses close to the target and can elute right beside the main peak.
• TFA salt adds mass, so net peptide content is often lower than purity.
• MS confirms molecular mass and helps identify impurities.